Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

£277,000 from the estate of Jean Williams will support cutting-edge studies into macular disease, which affects nearly 1.5 million people.

Researcher and participant carrying out eye research on computers behind each other

Macular disease can have a devastating impact on people’s lives, leaving them unable to read, drive and recognise faces. It affects the macula – a small but significant part of the retina that is responsible for all of our central vision, most of our colour vision and our ability to see in fine detail.

There are many different forms of macular disease, but age-related macular disease (AMD) is the most common, typically affecting people aged over 50. There are also a large number of rare, inherited conditions known as macular dystrophies. These can manifest in childhood, although others do not present until later in life.

We are so grateful for the Jean Williams donation. This will have such a huge impact on our ability to carry out research into the causes and treatments for inherited macular disease.
- Susan Downes, Professor of Ophthalmology and Consultant Ophthalmic Surgeon

The Nuffield Department of Clinical Neurosciences is a centre of excellence for research into retinal diseases, of which macular disease and macular degeneration form a significant proportion. We bring together clinician scientists and research scientists to advance understanding of these conditions, and to find new treatments using stem cell therapy, gene therapy and enhanced electronic devices.

Thanks to Mrs Williams’ generous legacy – which came to Oxford via the Charities Aid Foundation – our researchers will undertake a range of pioneering studies into macular disease. Subjects under investigation include the structure and function of the brain’s response to inherited macular disease, and the effect of different gene-targeted approaches to AMD.

Another of the studies will explore unsolved cases of inherited macular dystrophies, with researchers using next-generation DNA sequencing data to identify the genes and variants responsible. In these cases, patients will be provided with a diagnosis and information regarding inheritance patterns in their families, and any novel genes discovered will be used to develop future treatments.

Mrs Williams, who passed away in 2017 at the age of 96, was diagnosed with inherited macular dystrophy when she was a child. Her cousin and executrix Jan Winstanley, says: ‘Blindness doesn’t affect just one person, it affects the whole family. The Nuffield Department of Clinical Neurosciences is doing astonishing things in the field, so I am excited to see what happens in the next few years. My mother, grandmother and great grandmother were also affected by the disease, and while unfortunately this ground-breaking research couldn’t help my family, it could help millions of people.’

Support the Nuffield Department of Clinical Neurosciences

Similar stories

New genetic diagnosis technology for eye disease receives major funding award

Eye2Gene explores the use of AI to determine which genetic condition is causing a patient’s inherited retinal disease, by examining eye scans.

Royal Commission Industrial Fellowship for Andrei-Claudiu Roibu with F. Hoffmann-La Roche Ltd

Mapping brain network activity from structural connectivity using deep learning

Researchers awarded Wellcome Innovator Grant to investigate role of brainstem nucleus in human consciousness

Researchers at Oxford University have received a prestigious Wellcome Innovator Grant for investigating the role of the pedunculopontine nucleus (PPN) – a brainstem nucleus – in human consciousness.

How our dreams changed during the COVID-19 pandemic

This study explored associations between COVID-19 and dream recall frequency, and related social, health, and mental health factors.

New insights into the effect of exposure to dim light in the evening on the biology of the sleep-wake cycle

A new study has revealed more about how exposure to dim light in the evening affects circadian health. The findings emphasise the need to optimise our artificial light exposure if we are to avoid shifting our biological clocks.

Blood lipoprotein levels linked to future risk of amyotrophic lateral sclerosis

Greater understanding of the role of lipoproteins could support screening and efforts to develop treatments.